Prothena | PRTA - EPS - Lucro por Ação

Preço das Ações
10.75
Mudança Diária
0.02 0.19%
Mensal
15.47%
Anual
10.82%
Q2 Previsão
10.43

Fiscal Calendário Atual Consenso Anterior Data
FY2027Q1 Mar/2026 -0.35 -1.12 May/13




Eps Alterar Data
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Akebia Therapeutics USD -0.04 0.04 2025-12
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Exelixis USD 0.97 0.19 2025-12
Immunic USD -0.24 0.03 2024-09
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
MacroGenics USD -0.22 0.49 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Prothena USD -0.46 0.22 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xoma USD -1.59 2.43 2024-09